Terug
15
Dagbereik
€ 101,10
€ 103,02
52-Weeksbereik
€ 47,48
€ 107,90
Volume
50.204
50D / 200D Gem.
€ 100,42
/
€ 81,20
Vorige Slotkoers
€ 100,97
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 57,9 | 0,2 |
| P/B | 13,8 | 3,0 |
| ROE % | 24,8 | 3,6 |
| Net Margin % | 26,8 | 3,8 |
| Rev Growth 5Y % | 19,0 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 120,00
+17.9%
Forward K/W
48,93
Forward WPA
€ 2,08
WPA Groei (sch.)
+0,0%
Omzet Sch.
91,92M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 2,32
€ 2,30 – € 2,34
|
101,14M | 1 |
| FY2026 |
€ 2,08
€ 2,07 – € 2,09
|
91,92M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-10 | € 0,48 | € 0,54 | +12,5% |
| 2025-11-03 | € 0,48 | € 0,47 | -2,1% |
| 2025-08-01 | € 0,45 | € 0,49 | +8,9% |
| 2025-05-05 | € 0,43 | € 0,42 | -2,3% |
| 2025-02-13 | € 0,45 | € 0,44 | -2,2% |
| 2024-10-31 | € 0,39 | € 0,43 | +10,3% |
| 2024-08-01 | € 0,37 | € 0,42 | +13,5% |
| 2024-05-02 | € 0,34 | € 0,36 | +5,9% |
Dividend History
4 yr streakYield
0,01%
Payout Ratio
0,67%
Growth (3Y)
5,67%
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 23, 2026 | Mar 06, 2026 | € 0,20 | 1,20% |
| Dec 17, 2025 | Dec 30, 2025 | € 0,50 | 1,26% |
| Nov 14, 2025 | Nov 25, 2025 | € 0,17 | 0,81% |
| Aug 18, 2025 | Aug 28, 2025 | € 0,17 | 0,94% |
| May 20, 2025 | May 30, 2025 | € 0,17 | 1,20% |
| Feb 24, 2025 | Mar 05, 2025 | € 0,17 | 1,12% |
| Nov 15, 2024 | Nov 25, 2024 | € 0,15 | 0,87% |
| Aug 20, 2024 | Aug 30, 2024 | € 0,15 | 2,11% |
| May 17, 2024 | May 30, 2024 | € 0,15 | 1,86% |
| Dec 21, 2023 | Jan 12, 2024 | € 0,63 | 1,37% |
| Feb 10, 2023 | Feb 21, 2023 | € 1,05 | 2,91% |
| Feb 16, 2022 | Feb 24, 2022 | € 1,00 | 2,02% |
Belangrijkste Punten
Revenue grew 18,99% annually over 5 years — strong growth
Earnings grew 16,88% over the past year
ROE of 24,78% indicates high profitability
Net margin of 26,82% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 17,18M in free cash flow
Groei
Revenue Growth (5Y)
18,99%
Revenue (1Y)14,43%
Earnings (1Y)16,88%
FCF Growth (3Y)77,43%
Kwaliteit
Return on Equity
24,78%
ROIC20,73%
Net Margin26,82%
Op. Margin31,20%
Veiligheid
Debt / Equity
0,00
Current Ratio7,98
Interest Coverage0,00
Waardering
P/E Ratio
57,87
Forward P/E48,93
P/B Ratio13,75
EV/EBITDA47,80
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14,43% | Revenue Growth (3Y) | 13,07% |
| Earnings Growth (1Y) | 16,88% | Earnings Growth (3Y) | 14,35% |
| Revenue Growth (5Y) | 18,99% | Earnings Growth (5Y) | 24,60% |
| Profitability | |||
| Revenue (TTM) | 83,81M | Net Income (TTM) | 22,48M |
| ROE | 24,78% | ROA | 20,67% |
| Gross Margin | 76,75% | Operating Margin | 31,20% |
| Net Margin | 26,82% | Free Cash Flow (TTM) | 17,18M |
| ROIC | 20,73% | FCF Growth (3Y) | 77,43% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 7,98 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,67% |
| Dividend Growth (3Y) | 5,67% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 4 yrs | ||
| Valuation | |||
| P/E Ratio | 57,87 | Forward P/E | 48,93 |
| P/B Ratio | 13,75 | P/S Ratio | 15,52 |
| PEG Ratio | 3,35 | Forward PEG | N/A |
| EV/EBITDA | 47,80 | Fwd EV/EBITDA | 33,37 |
| Forward P/S | 14,15 | Fwd Earnings Yield | 2,04% |
| FCF Yield | 1,32% | ||
| Market Cap | 1,30B | Enterprise Value | 1,25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 83,81M | 73,24M | 65,56M | 53,30M | 41,81M |
| Net Income | 22,48M | 19,23M | 17,19M | 12,83M | 9,33M |
| EPS (Diluted) | 1,75 | 1,50 | 1,35 | 1,02 | 0,74 |
| Gross Profit | 64,32M | 56,35M | 50,16M | 41,28M | 32,05M |
| Operating Income | 26,15M | 21,96M | 20,04M | 15,63M | 9,82M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 108,78M | 98,33M | 92,16M | 85,51M | 82,88M |
| Total Liabilities | 14,16M | 11,51M | 20,74M | 11,84M | 10,71M |
| Shareholders' Equity | 94,62M | 86,82M | 71,42M | 73,67M | 72,17M |
| Total Debt | 0,0 | 154.688,0 | 2,04M | 2,21M | 2,48M |
| Cash & Equivalents | 51,16M | 52,23M | 49,76M | 57,96M | 62,00M |
| Current Assets | 81,20M | 75,24M | 76,00M | 77,49M | 76,24M |
| Current Liabilities | 10,18M | 8,51M | 16,33M | 8,55M | 6,82M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#152 of 158
Recente Activiteit
Ingestapt
Growth Investing (Philip Fisher)
Mar 24, 2026